The Semaglutide market is projected to expand from US$ 27.15 billion in 2024 to US$ 61.7 billion by 2033, with a CAGR of 9.55% from 2025. Driven by rising obesity and type 2 diabetes incidences, the ...

The conversation around Semaglutide, known widely by brand names like Ozempic and Wegovy, has undeniably captured global ...

Diabetes drug semaglutide linked to reduced risk of dementia in type 2 diabetes patients Effects strongest in women and older ...

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...

WEIGHT loss jabs could be rolled out by the NHS in pharmacies under plans to make them more widely available and “tackle the ...

You’ve probably heard of the semaglutide brand names Ozempic®, Wegovy, and Rybelsus. You may have even heard about affordable options like compounded semaglutide.

Patients have been referred to hospital emergency departments after mistakenly overdosing on diabetes drugs such as Ozempic, ...

Amanda Bynes revealed her decision to start Ozempic to lose more than 40 pounds, improve her health and feel confident in paparazzi photos ...

Danish drugmaker Novo Nordisk has launched its popular weight-loss drug Wegovy in India, months after its rival Mounjaro’s ...

A new study has found that people with type 2 diabetes who take semaglutide—a drug commonly known by its brand names Ozempic ...

A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...

Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery ...